检索

标题
作者
Calculation of cardiovascular risk in patients with premature ovarian insufficiency depending on its etiology
Lopukhov S., Nikiforov A., Filippov E.
Epidemiology of atherosclerotic cardiovascular diseases in some regions of the Russian Federation, clinical characteristics of patients and estimation of the efficacy of lipid-lowing therapy: study of real clinical practice
Tuaeva I., Astakhova Z.
Gut microbiome modulation and cardiovascular risks: mechanisms of formation and correction
Livzan M., Bikbavova G., Safiulina T., Loginova E.
Left-sided infectious endocarditis in a patient receiving program hemodialysis treatment
Ponomareva E., Sedov D.
Patients with cardiovascular diseases and NSAIDs intake: is there a real problem today?
Rebrov A., Tyapkina M., Ordyakova A., Yupatov V., Kosheleva N., Basov I.
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening
Larina V., Lankin A., Larin V., Golovko M.
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants
Borovkova N., Kurashin V., Tokareva A., Makarova E., Nekrasov A., Savitskaya N., Mironov M.
Diagnostic and therapeutic aspects of irisin in cardiovascular pathology and metabolic disorders
Alieva A., Nikitin I., Teplova N., Baykova I., Rakhaev A., Kudaeva M., Sozaeva M., Kotikova I.
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care
Demidova T., Izmailova M.
Inflammatory bowel diseases and cardiovascular pathology: pathogenetic correlations and age-related peculiarities
Khlynova O., Stepina E., Trapeznikova A.
New possibilities of uratedecreasing therapy in patients with arthrolithiasis
Petrova M., Musiichuk M., Inamova O., Mazurov V.
Effect of platelets on the course of rheumatoid arthritis and cardiovascular risk
Mazurov V., Melnikov E., Bashkinov R.
Prognostic value of cardiac troponins in case of COVID-19
Alieva A., Reznik E., Teplova N., Batov M., Shnahova L., Arakelyan R., Baykova I., Totolyan G., Volynkina V., Kislyakov V., Nikitin I.
The role of interleukin 12 in the development of cardiovascular diseases
Alieva A., Teplova N., Ettinger O., Reznik E., Baykova I., Sarakaeva L., Shnahova L., Arakelyan R., Valiev R., Nikitin I.
Possibility ofhigh-selective adrenoblockers use in combined therapy of patients with metabolic syndrome
Tolpygina S.
Review of current opportunities in cardiovascular risks management in patients with type 2 diabetes mellitus
Demidova T., Mkrtamyan A.
Estimation of hypolipidemic psillium effect in gastroenterologic patients with lipid metabolism disorders
Levchenko S., Komissarenko I.
Arterial hypertension and longevity
Reznik E., Golubev Y., Zhuravlev A., Yurtaeva N., Ischenko G.
JDP2 - a new promising biological marker in cardiovascular pathology
Alieva A., Reznik E., Teplova N., Totolyan G., Gasanova E., Kalova M., Sabanchieva E., Nikitin I.
Resistin and cardiovascular pathology
Alieva A., Baykova I., Khadzhieva N., Ettinger O., Arakelyan R., Valiev R., Rakhaev A., Batov M., Elmurzaeva D., Malkarova D., Nikitin I.
About fundamental and clinical aspects of magnesium and ribolavine synergic action in therapeutic practice
Gromova O., Torshin I., Kobalava Z., Sorokina M.
The importance of a multifactorial approach in the treatment of type 2 diabetes mellitus: clinical cases
Podorozhnyuk K., Skuridina D.
INTERLEUKIN 37 IS A NEW BIOLOGICAL MARKER FOR CARDIOVACULAR PATHOLOGY
Alieva A., Reznik E., Teplova N., Arakelyan R., Shnakhova L., Baykova I., Akkieva M., Nikitin I.
Issues of pathogenesis of cognitive and psychoemotional disorders in patients with cardiovascular and metabolic diseases
Shishkova V., Kotova M., Kapustina L., Imamgayazova K.
Prevalence of some managed risk factors of cardiovascular diseases among young students
Kardangusheva A., Shugusheva Z., Bekulova I., Bekaidieva N., TEUNOVA M.
PECULIARITIES OF CARDIOVASCULAR OUTCOMES IN MALE AND FEMALE PATIENTS AFTER NOVEL CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2
Glibko K., Arakelov S., Titova I., Kasaeva D., Larina V.
Type 2 diabetes mellitus and cardiovascular diseases. Therapy that changes prognosis
Demidova T., Pugovkina Y.
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
Derevyanchenko M., Fedotov V., Shaposhnikova M., Kolodin S.
Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications
Yermakova Y., Kochergina I.
Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases
Alieva A., Teplova N., Reznik E., Valiev R., Rakhaev A., Kudaeva M., Akhmatov I., Arakelyan R., Nikitin I.
COVID-19 and cardiovascular diseases: a dangerous tandem
Avdeeva I., Burko N., Makarova K., Makarova K., Oleynikov V.
CARDIOVASCULAR DISEASES AT THE PREHOSPITAL STAGE: HOW TO IMPROVE THE EFFECTIVENESS OF CARE?
Mychka V., Uzueva E.
Practical issues of oral iron administration for anemia in patients with cardiovascular diseases
Posnenkova O., Kaluta T.
The relationship of environmental risk factors and cardiovascular diseases in hypertensive patients living in rural areas
Yesina E., Zuikova A., Kotova Y.
1 - 34 的 34 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##